Real-world utilization, safety and patient experience of 20% subcutaneous immunoglobuin in patients with primary immunodeficiencies: final data from the core study

Fasshauer, Maria; Borte, Michael; Bitzenhofer, Michaela; Pausch, Christine; Pittrow, David; Park, Michelle; Gladiator, André; Jandus, Peter (2022). Real-world utilization, safety and patient experience of 20% subcutaneous immunoglobuin in patients with primary immunodeficiencies: final data from the core study (Unpublished). In: ESID Kongress Gothenburg 2022.

[img]
Preview
Text
Bitzenhofer_Real-World.pdf - Other
Available under License BORIS Standard License.

Download (441kB) | Preview

Item Type:

Conference or Workshop Item (Poster)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Rheumatology, Clinical Immunology and Allergology
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Pneumology

UniBE Contributor:

Bitzenhofer-Grüber, Michaela Aphrodite

Subjects:

600 Technology > 610 Medicine & health

Language:

English

Submitter:

Heidi Lobsiger

Date Deposited:

07 Dec 2022 14:03

Last Modified:

07 Dec 2022 18:38

BORIS DOI:

10.48350/175541

URI:

https://boris.unibe.ch/id/eprint/175541

Actions (login required)

Edit item Edit item
Provide Feedback